Dataset Information

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.

ABSTRACT:

Background

Thromboembolic disease is common in coronavirus disease-2019 (COVID-19). There is limited evidence on the association of in-hospital anticoagulation (AC) with outcomes and postmortem findings.

Objectives

The purpose of this study was to examine association of AC with in-hospital outcomes and describe thromboembolic findings on autopsies.

Methods

This retrospective analysis examined the association of AC with mortality, intubation, and major bleeding. Subanalyses were also conducted on the association of therapeutic versus prophylactic AC initiated ≤48 h from admission. Thromboembolic disease was contextualized by premortem AC among consecutive autopsies.